Baxter met Q2 expectations but lowered full-year earnings and sales guidance due to weakness in Medical Products & Therapies.
Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook
Where Today's News Shapes Tomorrow
March 5, 2026
Headlines
